Hi, and Happy Friday! At our Q1 IR Roundtable event, How ESG Drives Trust Among Investors and Patients Alike, our guest speakers dug into ESG with a biopharma lens, exploring how we can approach ESG in a way that strengthens credibility. ESG is most effective when it helps stakeholders understand how a company manages risk and makes decisions, rather than being positioned as a separate corporate responsibility exercise. If you weren’t able to join us live, T2B Pro and Student members can...
10 days ago • 2 min read
Hi! At our very first Patient Advocacy & Engagement Roundtable discussion, Patient Stories Without a Fixed Address, the conversation with leaders from Astellas, Bayer, and Atrium Therapeutics focused on what patient centricity looks like when it is treated as a strategic business priority. A consistent theme emerged: Organizations that build strong patient relationships tend to do so by embedding patient perspectives early, operationalizing what they hear, and protecting the integrity of the...
13 days ago • 1 min read
Hi! Applications for the T2B Students & Recent Grads Roundtable are now open and will close March 30th. This group brings together students and recent graduates interested in building careers in biopharma communications. Participants will help shape programming for their peers while building practical skills, expanding their networks, and gaining real exposure to senior leaders across the industry. We have five seats available for this year's roundtable. Apply here A few things to know: Led...
14 days ago • 1 min read
Hi, and Happy Friday! At our Q1 AI Roundtable webinar, Beyond ChatGPT: The AI Toolkit Every Communicator Needs in 2026, we got into the nitty-gritty of integrating AI into comms workflows. The discussion spanned research, drafting, stakeholder intelligence, and content production. T2B Pro members can click here to watch the replay and browse a comprehensive list of the resources shared. Top 10 Takeaways Recognize that AI can start to lead you. Front-loading context and expertise keeps you in...
17 days ago • 1 min read
Hi! A reminder that tomorrow (Friday the 13th!) at noon ET / 9 a.m. PT / 4 p.m. GMT we’re continuing our T2B IR Roundtable programming with a session on Environmental, Social, and Governance (ESG) strategies: Beyond the Checkbox: How ESG Drives Trust Among Investors and Patients Alike We’ll explore practical insights and considerations for biopharma companies at every stage of their ESG journey: How to right-size your ESG program and communications based on company stage and resources Ways to...
18 days ago • 1 min read
Hi! After the snow forced us to postpone our Boston and NY/NJ T2Bmeets earlier this quarter, we’re glad to have them back on the calendar. Following our networking mixer at JPM to start the year, we’re now looking ahead to three in-person T2Bmeets across the country — in Boston (March 31st), New Jersey (April 1st), and San Diego (April 23rd). These meetups combine panel discussion and informal networking, depending on the city. If you’re local (or traveling), we hope you’ll join us for a...
20 days ago • 2 min read
Hi! At our February Comm Convo, Fighting Misinformation Without Amplifying It, we examined the practical reality biopharma communicators navigate every day: A fast-moving information environment where incomplete, misleading, or distorted claims can gain traction quickly. There is rarely a clean or standard how-to for responding when misinformation spreads. Instead, effective responses depend on preparation, cross-functional alignment, and disciplined judgment about when engagement adds...
25 days ago • 2 min read
Hi! A quick reminder that tomorrow is our inaugural PA&E Roundtable event. Wherever the patient advocacy function formally sits in an organization research, communicators are often the ones helping translate those patient insights into stories that resonate internally and externally. Tomorrow’s conversation will explore how teams gather those insights, how communicators partner across functions, and what it takes to represent patient experiences thoughtfully and responsibly in our work. The...
26 days ago • 1 min read
Hi! As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations. But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics. Our March Comm Convo brings together communicators who have worked in and out of life sciences to...
27 days ago • 1 min read